David Wang
Impact in
- Neurology top 0.1%
- Long-Term Effects of COVID-19
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Epidemiology 79
- Acute Ischemic Stroke Management 54
- Influenza Virus Research Studies 13
- Neurology 33
- Intracerebral and Subarachnoid Hemorrhage Research 8
- Co-authors
- Bo Hu (10 shared papers)Yanan Li (7 shared papers)Huijuan Jin (6 shared papers)Ling Mao (5 shared papers)Yifan Zhou (6 shared papers)Jiang Chang (6 shared papers)Mengdie Wang (3 shared papers)Yongjun Wang (47 shared papers)
- Journals
- Stroke and Vascular Neurology (26 papers)Stroke (22 papers)Journal of Biomedical Science (13 papers)Neurology (12 papers)Emerging infectious diseases (7 papers)
- Partner nations
- United StatesChinaTaiwan
In The Last Decade
David Wang
257 papers receiving 18.7k citations
David Wang's Hit Papers
Peers
Comparison fields: 5 of 182
- Neurology 5.5k
- Infectious Diseases 3.3k
- Neurology 1.3k
- Critical Care and Intensive Care Medicine 671
- Epidemiology 4.2k
Countries citing papers authored by David Wang
This map shows the geographic impact of David Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wang more than expected).
Fields of papers citing papers by David Wang
This network shows the impact of papers produced by David Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wang. The network helps show where David Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside David Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 270 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China Hit paper breakdown → | 2020 | 5252 |
| 2 | Prevalence, Incidence, and Mortality of Stroke in China Hit paper breakdown → | 2017 | 1599 |
| 3 | Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack Hit paper breakdown → | 2013 | 1336 |
| 4 | An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Hit paper breakdown → | 1985 | 1112 |
| 5 | Pioglitazone after Ischemic Stroke or Transient Ischemic Attack Hit paper breakdown → | 2016 | 888 |
| 6 | Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study Hit paper breakdown → | 2020 | 750 |
| 7 | Stroke and Stroke Care in China Hit paper breakdown → | 2011 | 660 |
| 8 | Formal Dysphagia Screening Protocols Prevent Pneumonia Hit paper breakdown → | 2005 | 445 |
| 9 | China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Hit paper breakdown → | 2020 | 373 |
| 10 | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations Hit paper breakdown → | 2022 | 277 |
| 11 | Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke Hit paper breakdown → | 2021 | 203 |
| 12 | 2004 | 200 | |
| 13 | 2015 | 176 | |
| 14 | 2011 | 165 | |
| 15 | 2014 | 149 | |
| 16 | 2020 | 130 | |
| 17 | 2013 | 124 | |
| 18 | 2011 | 123 | |
| 19 | 2022 | 122 | |
| 20 | 2009 | 119 |
About David Wang
David Wang is a scholar working on Epidemiology, Neurology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Rehabilitation, having authored 270 papers that have together received 19.3k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (54 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Cerebrovascular and Carotid Artery Diseases (13 papers), Influenza Virus Research Studies (13 papers), Nitric Oxide and Endothelin Effects (11 papers), Palliative Care and End-of-Life Issues (9 papers), Stroke Rehabilitation and Recovery (9 papers) and Intracerebral and Subarachnoid Hemorrhage Research (8 papers). The work is most often cited by research in Neurology (5.5k citations), Infectious Diseases (3.3k citations), Neurology (1.3k citations), Critical Care and Intensive Care Medicine (671 citations) and Epidemiology (4.2k citations). David Wang has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Bo Hu, Yanan Li, Huijuan Jin, Ling Mao, Yifan Zhou, Jiang Chang, Mengdie Wang, Yongjun Wang, Candong Hong and Quanwei He. Their work appears in journals such as Stroke and Vascular Neurology, Stroke, Journal of Biomedical Science, Neurology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.